Related Experiment Video
Updated: Mar 1, 2026
13:25
Transient Transduction of the Strobilated Forms of Echinococcus granulosus
Published on: September 16, 2022
3.6K
[CLINICAL AND EPIDEMIOLOGICAL PECULIARITIES OF CYSTIC ECHINOCOCCOSIS IN CHILDREN]
Kh Melia1, N Kokaia1, M Manjgaladze1
11Institute of Medical Parasitology and Tropical Medicine; 2Tbilisi State Medical University, Georgia.
Georgian Medical News
|June 3, 2017
Summary
Postoperative cystic echinococcosis in children showed positive outcomes with no relapses. Ultrasound monitoring revealed favorable cyst development and suggested liver connective tissue changes post-treatment.
Area of Science:
- Pediatric Surgery
- Infectious Diseases
- Medical Imaging
Background:
- Cystic echinococcosis is a parasitic infection requiring careful postoperative management.
- Pediatric cases present unique diagnostic and therapeutic challenges.
- Understanding long-term outcomes is crucial for effective patient care.
Purpose of the Study:
- To analyze the postoperative period of cystic echinococcosis in children.
- To evaluate cyst development, treatment efficacy, and serologic responses.
- To identify potential long-term changes in hepatic tissue.
Main Methods:
- Retrospective analysis of 13 pediatric patients diagnosed with cystic echinococcocosis.
- Inclusion of demographic, epidemiological, clinical, and serologic data.
- Monitoring of cyst status and hepatic tissue via serial ultrasound studies (US).
Main Results:
- The liver was the most commonly affected organ (76.9%).
- All patients demonstrated positive dynamics during the postoperative monitoring period.
- No relapses of cystic echinococcosis were observed.
- Ultrasound indicated the development of connective tissue in the liver.
Conclusions:
- Postoperative management of pediatric cystic echinococcosis appears effective with no observed relapses.
- Ultrasound is a valuable tool for monitoring cyst evolution and detecting hepatic changes.
- The study suggests a link between cystic echinococcosis and subsequent liver connective tissue development.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
293
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
392
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392
01:23Cystic Fibrosis: Pathogenesis
953
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
953
01:24Chronic Kidney Disease II: Clinical Manifestations
801
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
801
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
387
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
387
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
338
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
338